Activin Signal Transduction in Cell Growth, Differentiation and Apoptosis
Activin Signal Transduction in Cell Growth, Differentiation and Apoptosis
批准号:
08458199
负责人:
SUGINO Hiromu
金额:
$4.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Activin belonging to the TGF-beta superfamily binds to and signals through a receptor complex comprising two transmembrane serine/threonine kinases, called type I and type II.So far, two type II (ActR-IIA,-IIB) and two type I (ActR-IA,IB) activin receptors have been cloned from mammalian sources. In this study, we attempted to elucidate the role of type I receptors in activin signaling for growth, differentiation and apoptosis, and obtained following results.(1) We established stable HS-72 transfectants overexpressing ActR-IA or ActR-IB by the electroporation procedure. Overexpression of ActR-IA suppressed activin-induced cell-cycle arrest in the G1 phase caused by inhibition of retinoblastoma protein phosphorylation through induction of p21, a cyclin-dependent kinase inhibitor, and subsequent apoptosis. In contrast, HS-72 clones that overexpressed ACtR-IB significantly facilitated activin induced apoptosis. These results indicate that ActR-IA and ActR-IB are distinct from each other in activin signal transduction.(2) Significant degradation of a cytoskeleton, alpha-fodrin was observed upon activin-induced apoptosis in HS-72 cells. Overexpression of ActR-IA in HS-72 cells caused prevention of the alpha-fodrin degradation, suggesting that the apoptotic signal of activin in relevant to the proteolytic degradation of alpha-fodrin.(3) Follistatin (activin-binding protein) was found to promote the binding of activin to cell surface heparan sulfate. When the cells were incubated with ^<125>I-activin in the presence of follistatin, significant degradation of activin was observed. This activin degradation was abolished by heparan sulfate, chloroquine, and lysosomal protease inhibitors. These results indicate that cell-associated follistatin accelerates the uptake of activin into cells, leading to increased degradation by lysosomal enzymes, and thus plays a role in the activin clearance system.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Hiromu Sugino: "Follistatin and its role as an activin-binding protein" The Journal of Medical Investigation. 44. 1-14 (1997)
Hiromu Sugino:“卵泡抑素及其作为激活素结合蛋白的作用”《医学调查杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Norio Haneji: "Identification of α-fodrin as a candidate autoantigen in primary Sjogren′s syndrome" Science. 276. 604-607 (1997)
Norio Haneji:“α-胞质蛋白作为原发性干燥综合征候选自身抗原的鉴定”《科学》276. 604-607 (1997)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hiromu Sugino: "Follistatin and its role as a activin-bindingprotein" The Journal of Medical Investigation. 44. 1-14 (1997)
Hiromu Sugino:“卵泡抑素及其作为激活素结合蛋白的作用”《医学调查杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Johan P.de Winter: "Follistatin neutralize activin bioactibity by inhibition of activin binding to its type II receptors" Molec.Cell.Endocrinol.116. 105-114 (1996)
Johan P.de Winter:“卵泡抑素通过抑制激活素与其 II 型受体的结合来中和激活素的生物活性”Molec.Cell.Endocrinol.116。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Osamu Hashimoto: "A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells" J.Biol.Chem.272. 13835-13842 (1997)
Osamu Hashimoto:“卵泡抑素(一种激活素结合蛋白)在抑制大鼠垂体细胞激活素作用中的新作用”J.Biol.Chem.272。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 16 条
Intracellular and extracellular control of activin signaling by novel regulatory molecules
-
批准号:15370058
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.79万
-
财政年份:2003
-
负责人:SUGINO Hiromu
-
依托单位:
Regulation Mechanisms for Activin Signaling
-
批准号:13480210
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.66万
-
财政年份:2001
-
负责人:SUGINO Hiromu
-
依托单位:
Activin signal transduction and its regulation mechanisms
-
批准号:10480170
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$7.68万
-
财政年份:1998
-
负责人:SUGINO Hiromu
-
依托单位:
Roles of activin/follistatin in neural induction
-
批准号:10044298
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$3.07万
-
财政年份:1998
-
负责人:SUGINO Hiromu
-
依托单位:
Mesoderm and neuron induction and activin signaling
-
批准号:09044316
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$1.54万
-
财政年份:1997
-
负责人:SUGINO Hiromu
-
依托单位:
Neuronal differentiation and activin signal transduction
-
批准号:08044298
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$1.54万
-
财政年份:1996
-
负责人:SUGINO Hiromu
-
依托单位:
The role of activin binding protein in the activin signal transduction.
-
批准号:04454597
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.22万
-
财政年份:1992
-
负责人:SUGINO Hiromu
-
依托单位:
Signal Transduction Mechanism in differentiation and Development of Follicular Granulosa Cells.
-
批准号:02454541
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.35万
-
财政年份:1990
-
负责人:SUGINO Hiromu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
AAV介导sTGF-betaRII抑制TGF-beta/Smad2/3信号通路的抗口腔黏膜下纤维化基因治疗研究
-
批准号:JCZRLH202600804
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
TGF-beta通路通过降低自噬-基因组稳定性介导胶质母细胞瘤间质亚型替莫唑胺耐药的机制研究
-
批准号:82303919
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈鹭跃
-
依托单位:
靶向TGF-beta Ⅱ型受体的核酸适配子对TGF-beta介导PCO形成的抑制作用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:朱小敏
-
依托单位:
癌基因FBN2通过TGF-beta通路促进胃癌肝转移的分子机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:舒洋
-
依托单位:
转录因子FOXA1对TGF-beta介导的肺癌细胞上皮-间充质转化调控作用的研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:王学聪
-
依托单位:
端粒缩短触发NLRP3/TGF-beta/Smad3信号通路对IgA肾病重症进展的调控研究
-
批准号:82100738
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:任萍萍
-
依托单位:
BRD2 通过相变调控 TGF-beta 信号通路的分子机制和功能研究
-
批准号:LZ22C070001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:顾舒晨
-
依托单位:
非经典TGF-beta信号通路调控小肠干细胞稳态的作用及机制研究
-
批准号:32000538
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:刘连胜
-
依托单位:
TGF-beta信号通路促进人类T细胞白血病1型病毒侵染的作用及其机制研究
-
批准号:LY21C010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:赵铁军
-
依托单位:
TGF-beta信号通调控淋巴管形成在单纯疱疹病毒性角膜炎治疗中的作用
-
批准号:82060175
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2020
-
负责人:张慧
-
依托单位: